Respiree

Respiree is a health technology company that specializes in AI-powered solutions for managing cardio-respiratory diseases. The company develops clinically validated artificial intelligence and machine learning models, integrated with proprietary breath-cardio sensors, to enable early detection and monitoring of disease progression. Their flagship platform, 1Bio™, combines data from electronic health records and FDA-cleared sensors to track patient health over time, supporting both inpatient and home-based care. Respiree offers two main solutions: Respiree Care, an enterprise-connected remote care platform for managing healthcare across various settings, and Respiree 1Bio, a decentralized clinical trials platform that integrates numerous pulmonary and cardiovascular biomarkers for remote patient monitoring. The company’s products are FDA 510(k) cleared and CE marked, with certifications for HIPAA and FDA cybersecurity compliance, ISO 13485 quality management, and ISO 27001:2022 information security standards. Respiree's technology aims to enhance patient outcomes by providing precise alerts and improving early detection of health deterioration.

• Employees 33
• Founded 2019
• Total Funding $15000000